# Mipharm S.p.A. – FDA Inspection, Sep 22, 2023

Source: https://www.keypedia.com/records/fda_inspections/mipharm-spa/cc148a53-3099-4984-9987-6d1113bbbb60
Source feed: FDA_Inspections

> FDA inspection 1219480 of Mipharm S.p.A., September 22, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219480
- Company Name: Mipharm S.p.A.
- Inspection Date: 2023-09-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1133100 - 2019-10-17
- [FDA Inspection 1004998 - 2017-02-03](https://www.keypedia.com/records/fda_inspections/mipharm-spa/6079ccf1-30c3-4af0-b5a6-e75d46f17ad5)
- FDA Inspection 870680 - 2014-02-14
- FDA Inspection 853837 - 2013-09-27
- FDA Inspection 731940 - 2011-06-10

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/rajiv-r-srivastava/05b42bfd-0cf4-42ce-89e1-b81bf36eaa17)

Company: https://www.keypedia.com/companies/mipharm-spa/5bbbfcd9-7f44-434e-a097-60a4d9f446bc

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c